262 related articles for article (PubMed ID: 33941403)
1. Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk.
Darst BF; Sheng X; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA
Eur Urol; 2021 Aug; 80(2):134-138. PubMed ID: 33941403
[TBL] [Abstract][Full Text] [Related]
2. Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African Ancestry.
Hughley RW; Matejcic M; Song Z; Sheng X; Wan P; Xia L; Hart SN; Hu C; Yadav S; Lubmawa A; Kiddu V; Asiimwe F; Amanya C; Mutema G; Job K; Ssebakumba MK; Ingles SA; Hamilton AS; Couch FJ; Watya S; Conti DV; Darst BF; Haiman CA
Cancer Res Commun; 2023 Dec; 3(12):2544-2550. PubMed ID: 38014910
[TBL] [Abstract][Full Text] [Related]
3. A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.
Karlsson R; Aly M; Clements M; Zheng L; Adolfsson J; Xu J; Grönberg H; Wiklund F
Eur Urol; 2014 Jan; 65(1):169-76. PubMed ID: 22841674
[TBL] [Abstract][Full Text] [Related]
4. Clinical Utility of Germline Genetic Testing in Japanese Men Undergoing Prostate Biopsy.
Akamatsu S; Terada N; Takata R; Kinoshita H; Shimatani K; Momozawa Y; Yamamoto M; Tada H; Kawamorita N; Narita S; Kato T; Nitta M; Kandori S; Koike Y; Inazawa J; Kimura T; Kimura H; Kojima T; Terachi T; Sugimoto M; Habuchi T; Arai Y; Yamamoto S; Matsuda T; Obara W; Kamoto T; Inoue T; Nakagawa H; Ogawa O
JNCI Cancer Spectr; 2022 Feb; 6(1):. PubMed ID: 35118230
[TBL] [Abstract][Full Text] [Related]
5. Homeobox B13 G84E Mutation and Prostate Cancer Risk.
Nyberg T; Govindasami K; Leslie G; Dadaev T; Bancroft E; Ni Raghallaigh H; Brook MN; Hussain N; Keating D; Lee A; McMahon R; Morgan A; Mullen A; Osborne A; Rageevakumar R; ; Kote-Jarai Z; Eeles R; Antoniou AC
Eur Urol; 2019 May; 75(5):834-845. PubMed ID: 30527799
[TBL] [Abstract][Full Text] [Related]
6. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility.
Emami NC; Cavazos TB; Rashkin SR; Cario CL; Graff RE; Tai CG; Mefford JA; Kachuri L; Wan E; Wong S; Aaronson D; Presti J; Habel LA; Shan J; Ranatunga DK; Chao CR; Ghai NR; Jorgenson E; Sakoda LC; Kvale MN; Kwok PY; Schaefer C; Risch N; Hoffmann TJ; Van Den Eeden SK; Witte JS
Cancer Res; 2021 Apr; 81(7):1695-1703. PubMed ID: 33293427
[TBL] [Abstract][Full Text] [Related]
7. Validation of a multi-ancestry polygenic risk score and age-specific risks of prostate cancer: A meta-analysis within diverse populations.
Chen F; Darst BF; Madduri RK; Rodriguez AA; Sheng X; Rentsch CT; Andrews C; Tang W; Kibel AS; Plym A; Cho K; Jalloh M; Gueye SM; Niang L; Ogunbiyi OJ; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Adjei AA; Diop H; Lachance J; Rebbeck TR; Ambs S; Gaziano JM; Justice AC; Conti DV; Haiman CA
Elife; 2022 Jul; 11():. PubMed ID: 35801699
[TBL] [Abstract][Full Text] [Related]
8. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry.
Chen F; Madduri RK; Rodriguez AA; Darst BF; Chou A; Sheng X; Wang A; Shen J; Saunders EJ; Rhie SK; Bensen JT; Ingles SA; Kittles RA; Strom SS; Rybicki BA; Nemesure B; Isaacs WB; Stanford JL; Zheng W; Sanderson M; John EM; Park JY; Xu J; Wang Y; Berndt SI; Huff CD; Yeboah ED; Tettey Y; Lachance J; Tang W; Rentsch CT; Cho K; Mcmahon BH; Biritwum RB; Adjei AA; Tay E; Truelove A; Niwa S; Sellers TA; Yamoah K; Murphy AB; Crawford DC; Patel AV; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas CM; Stern MC; Kote-Jarai Z; Govindasami K; Cook MB; Chokkalingam AP; Hsing AW; Goodman PJ; Hoffmann TJ; Drake BF; Hu JJ; Keaton JM; Hellwege JN; Clark PE; Jalloh M; Gueye SM; Niang L; Ogunbiyi O; Idowu MO; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Ajibola HO; Jamda MA; Oluwole OP; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Mensah JE; Diop H; Van Den Eeden SK; Blanchet P; Fowke JH; Casey G; Hennis AJ; Lubwama A; Thompson IM; Leach R; Easton DF; Preuss MH; Loos RJ; Gundell SM; Wan P; Mohler JL; Fontham ET; Smith GJ; Taylor JA; Srivastava S; Eeles RA; Carpten JD; Kibel AS; Multigner L; Parent MÉ; Menegaux F; Cancel-Tassin G; Klein EA; Andrews C; Rebbeck TR; Brureau L; Ambs S; Edwards TL; Watya S; Chanock SJ; Witte JS; Blot WJ; Michael Gaziano J; Justice AC; Conti DV; Haiman CA
Eur Urol; 2023 Jul; 84(1):13-21. PubMed ID: 36872133
[TBL] [Abstract][Full Text] [Related]
9. Breast and prostate cancer risk: The interplay of polygenic risk, rare pathogenic germline variants, and family history.
Hassanin E; May P; Aldisi R; Spier I; Forstner AJ; Nöthen MM; Aretz S; Krawitz P; Bobbili DR; Maj C
Genet Med; 2022 Mar; 24(3):576-585. PubMed ID: 34906469
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer.
Plym A; Penney KL; Kalia S; Kraft P; Conti DV; Haiman C; Mucci LA; Kibel AS
J Natl Cancer Inst; 2022 May; 114(5):771-774. PubMed ID: 33792693
[TBL] [Abstract][Full Text] [Related]
11. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
12. Germline Variants in DNA Damage Repair Genes and
Trendowski MR; Sample C; Baird T; Sadeghpour A; Moon D; Ruterbusch JJ; Beebe-Dimmer JL; Cooney KA
JCO Precis Oncol; 2022 Nov; 6():e2200460. PubMed ID: 36446039
[TBL] [Abstract][Full Text] [Related]
13. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry.
Darst BF; Hughley R; Pfennig A; Hazra U; Fan C; Wan P; Sheng X; Xia L; Andrews C; Chen F; Berndt SI; Kote-Jarai Z; Govindasami K; Bensen JT; Ingles SA; Rybicki BA; Nemesure B; John EM; Fowke JH; Huff CD; Strom SS; Isaacs WB; Park JY; Zheng W; Ostrander EA; Walsh PC; Carpten J; Sellers TA; Yamoah K; Murphy AB; Sanderson M; Crawford DC; Gapstur SM; Bush WS; Aldrich MC; Cussenot O; Petrovics G; Cullen J; Neslund-Dudas C; Kittles RA; Xu J; Stern MC; Chokkalingam AP; Multigner L; Parent ME; Menegaux F; Cancel-Tassin G; Kibel AS; Klein EA; Goodman PJ; Stanford JL; Drake BF; Hu JJ; Clark PE; Blanchet P; Casey G; Hennis AJM; Lubwama A; Thompson IM; Leach RJ; Gundell SM; Pooler L; Mohler JL; Fontham ETH; Smith GJ; Taylor JA; Brureau L; Blot WJ; Biritwum R; Tay E; Truelove A; Niwa S; Tettey Y; Varma R; McKean-Cowdin R; Torres M; Jalloh M; Magueye Gueye S; Niang L; Ogunbiyi O; Oladimeji Idowu M; Popoola O; Adebiyi AO; Aisuodionoe-Shadrach OI; Nwegbu M; Adusei B; Mante S; Darkwa-Abrahams A; Yeboah ED; Mensah JE; Anthony Adjei A; Diop H; Cook MB; Chanock SJ; Watya S; Eeles RA; Chiang CWK; Lachance J; Rebbeck TR; Conti DV; Haiman CA
Eur Urol; 2022 May; 81(5):458-462. PubMed ID: 35031163
[TBL] [Abstract][Full Text] [Related]
14. Genetics of prostate cancer and its utility in treatment and screening.
Benafif S; Ni Raghallaigh H; McHugh J; Eeles R
Adv Genet; 2021; 108():147-199. PubMed ID: 34844712
[TBL] [Abstract][Full Text] [Related]
15. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort.
Hoffmann TJ; Sakoda LC; Shen L; Jorgenson E; Habel LA; Liu J; Kvale MN; Asgari MM; Banda Y; Corley D; Kushi LH; Quesenberry CP; Schaefer C; Van Den Eeden SK; Risch N; Witte JS
PLoS Genet; 2015 Jan; 11(1):e1004930. PubMed ID: 25629170
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk.
Dite GS; Spaeth E; Murphy NM; Allman R
Prostate; 2023 Jul; 83(10):962-969. PubMed ID: 37062910
[TBL] [Abstract][Full Text] [Related]
17. Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients.
Maia S; Cardoso M; Pinto P; Pinheiro M; Santos C; Peixoto A; Bento MJ; Oliveira J; Henrique R; Jerónimo C; Teixeira MR
PLoS One; 2015; 10(7):e0132728. PubMed ID: 26176944
[TBL] [Abstract][Full Text] [Related]
18. The HOXB13 G84E Mutation Is Associated with an Increased Risk for Prostate Cancer and Other Malignancies.
Beebe-Dimmer JL; Hathcock M; Yee C; Okoth LA; Ewing CM; Isaacs WB; Cooney KA; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1366-72. PubMed ID: 26108461
[TBL] [Abstract][Full Text] [Related]
19. Genetic factors influencing prostate cancer risk in Norwegian men.
Chen H; Ewing CM; Zheng S; Grindedaal EM; Cooney KA; Wiley K; Djurovic S; Andreassen OA; Axcrona K; Mills IG; Xu J; Maehle L; Fosså SD; Isaacs WB
Prostate; 2018 Feb; 78(3):186-192. PubMed ID: 29181843
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Interaction of
Sipeky C; Gao P; Zhang Q; Wang L; Ettala O; Talala KM; Tammela TLJ; Auvinen A; Wiklund F; Wei GH; Schleutker J
Clin Cancer Res; 2018 Dec; 24(24):6265-6276. PubMed ID: 30181389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
